Peginterferon alpha-2a plus ribavirin in the retreatment of chronic hepatitis C patients, non-responders and relapsers to previous conventional interferon plus ribavirin therapy (2004)
- Authors:
- Parise, E. R.
- Meirelles, A.
- Martinelli, Ana de Lourdes Candolo
- Lacet, C.
- Crespo, D.
- Correa, E.
- Cotrim, H.
- Sette Júnior, Hoel
- Cheinquer, H.
- Gallizi, J.
- Fonseca, J.
- Pessoa, M.
- Lima, L.
- Pereira, L.
- Paraná, R.
- Silva, M. R.
- Teixeira, R.
- Spinelli, V.
- Amorim, W.
- Oliveira, A.
- Gomes, A.
- Villanova, M.
- Silva, R.
- Coelho-Borges, S.
- Tatsch, F.
- Autor USP: MARTINELLI, ANA DE LOURDES CANDOLO - FMRP
- Unidade: FMRP
- Assunto: HEPATITE C (TRATAMENTO)
- Language: Inglês
- Imprenta:
- Publisher place: Copenhagen
- Date published: 2004
- Source:
- Título do periódico: Liver International
- ISSN: 1478-3223
- Volume/Número/Paginação/Ano: v. 24, suppl.4, p. 16, res. OP-29
- Conference titles: Bienal Scientific Meeting of the International Association for the Study of the Liver
-
ABNT
PARISE, E. R. et al. Peginterferon alpha-2a plus ribavirin in the retreatment of chronic hepatitis C patients, non-responders and relapsers to previous conventional interferon plus ribavirin therapy. Liver International. Copenhagen: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 24 abr. 2024. , 2004 -
APA
Parise, E. R., Meirelles, A., Martinelli, A. de L. C., Lacet, C., Crespo, D., Correa, E., et al. (2004). Peginterferon alpha-2a plus ribavirin in the retreatment of chronic hepatitis C patients, non-responders and relapsers to previous conventional interferon plus ribavirin therapy. Liver International. Copenhagen: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Parise ER, Meirelles A, Martinelli A de LC, Lacet C, Crespo D, Correa E, Cotrim H, Sette Júnior H, Cheinquer H, Gallizi J, Fonseca J, Pessoa M, Lima L, Pereira L, Paraná R, Silva MR, Teixeira R, Spinelli V, Amorim W, Oliveira A, Gomes A, Villanova M, Silva R, Coelho-Borges S, Tatsch F. Peginterferon alpha-2a plus ribavirin in the retreatment of chronic hepatitis C patients, non-responders and relapsers to previous conventional interferon plus ribavirin therapy. Liver International. 2004 ; 24 16.[citado 2024 abr. 24 ] -
Vancouver
Parise ER, Meirelles A, Martinelli A de LC, Lacet C, Crespo D, Correa E, Cotrim H, Sette Júnior H, Cheinquer H, Gallizi J, Fonseca J, Pessoa M, Lima L, Pereira L, Paraná R, Silva MR, Teixeira R, Spinelli V, Amorim W, Oliveira A, Gomes A, Villanova M, Silva R, Coelho-Borges S, Tatsch F. Peginterferon alpha-2a plus ribavirin in the retreatment of chronic hepatitis C patients, non-responders and relapsers to previous conventional interferon plus ribavirin therapy. Liver International. 2004 ; 24 16.[citado 2024 abr. 24 ] - Alterações no sistema hepático de biotransformação do acetaminofen em ratos submetidos a modelo experimental (ingestão exclusiva de sacaroses) que previne efeitos hepatotóxicos da droga
- Relationship between concentration of hcv rna in the serum and its presence in saliva in patients with chronic hepatitis c
- Relationship between concentration of hcv rna in the serum and its presence in saliva in patients with chronic hepatitis c
- Hemorragia digestiva alta (HDA) em cirróticos: ocorrência e fatores relacionados. Experiência do HC-FMRP-USP
- Anticoagulation for liver fibrosis: a pilot study in hepatitis C infected patients
- HCV RNA <15 IU/mL at week 4 is highly predictive of SVR among HCV G2/3 patients receiving peginterferon alfa-2A/RBV: final results from potente study
- Peginterferon Alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels
- Effect of a thrombin receptor(protease-activated receptor 1-PAR-1)gene polymorphism in chronic hepatitis C liver fibrosis
- Ictericia
- Correlation between the levels of hcv in serem and liver of patientes with chronic hepatites
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
